Laser therapy for onychomycosis

Journal of Cutaneous Medicine and Surgery

Volumn 17, Issue 5, 2013, Pages 301-307

  Gupta, Aditya K ^a,b   Simpson, Fiona C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE;

CANDIDA ALBICANS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); HUMAN; IN VITRO STUDY; LOW LEVEL LASER THERAPY; MEDICAL TECHNOLOGY; NEODYMIUM YAG LASER; ONYCHOMYCOSIS; OUTCOME ASSESSMENT; PEER REVIEW; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; TRICHOPHYTON RUBRUM; DEVICES;

HUMANS; LASER THERAPY; ONYCHOMYCOSIS;

EID: 84885742082     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2012.12060     Document Type: Review

References (35)

1. Gupta AK, Simpson FC. New therapeutic options for onychomycosis. Expert Opin Pharmacother 2012;13:1131-42, doi:10.1517/14656566.2012.681779.
2. Zaias N. Onychomycosis. Arch Dermatol 1972;105:263-74, doi: 10.1001/archderm.1972.01620050069017.
3. Rashid A, Scott E, RichardsonMD. Early events in the invasion of the human nail plate by Trichophyton mentagrophytes. Br J Dermatol 1995;133:932-40, doi:10.1111/j.1365-2133.1995.tb06929.x. (Pubitemid 26008935)
4. Trichophyton: microscopic characterization and proteolytic enzymes. Med Mycol 2007;45:149-55, doi:10.1080/13693780601113618. (Pubitemid 46371957)
5. Burkhart CN, Burkhart CG, Gupta AK. Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm. J Am Acad Dermatol 2002;47:629-31, doi:10.1067/mjd.2002.124699.
6. Gupta AK, Drummond-Main C, Cooper EA, et al. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol 2012;66:494-502, doi:10.1016/j.jaad.2011.02.038.
7. Welsh O, Vera-Cabrera L, Welsh E. Onychomycosis. Clin Dermatol 2010;28:151-9, doi:10.1016/j.clindermatol.2009.12.006.
8. US Food and Drug Adminstration. Guidance documents (Medical devices and radiation-emitting products). The new 510(k) paradigm - Alternate approaches to demonstrating substantial equivalence in premarket notifications - Final guidance. 1998. Available at: http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/Guidance Documents/ucm080187.htm (accessed June 8, 2012).
9. Gupta AK, Ryder JE, Bluhm R, et al. Onychomycosis: quality of studies. J Cutan Med Surg 2003;7:312-6, doi:10.1007/s10227-002-0137-y. (Pubitemid 37419975)
10. Landsman AS, Robbins AH, Angelini PF, et al. Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure. J Am Podiatr Med Assoc 2010;100:166-77.
11. Landsman AS, Robbins AH. Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure: some follow-up observations at 270 days. J Am Podiatr Med Assoc 2012; 102:169-71.
12. Harris DM, McDowell BA, Strisower J. Laser treatment for toenail fungus. SPIE; 2009. Available at: http://spie.org/x648.html?product-id5810193 (accessed November 9, 2012).
13. Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser. J Cosmet Laser Ther 2011;13:2-5, doi:10.3109/14764172.2011.552616.
14. Kozarev J, Vižintin Z. Novel laser therapy in treatment of onychomycosis. J Laser Health Acad 2010;2010:1-8.
15. Kozarev J. ClearSteps - laser onychomycosis treatment: assessment of efficacy 12 months after treatment and beyond. J Laser Health Acad 2011;2011(1):S07.
16. Kimura U, Takeuchi K, Kinoshita A, et al. Treating onychomycoses of the toenail: clinical efficacy of the sub-millisecond 1,064 nm Nd:YAG laser using a 5 mm spot diameter. J Drugs Dermatol 2012; 11:496-504.
17. Weiss D. 3 month clinical results using sub-millisecond 1064 nm Nd:YAG laser for the treatment of onychomycosis. Weiss Foot and Ankle Center; 2011. Available at: http://conejofeet.com/wp-content/uploads/2011/06/David-Weiss-DPM- report.pdf (accessed May 30, 2012).
18. Waibel J. Introducing the Sciton ClearSense accessory featuring the ClearToe treatment for onychomycosis (for non-U.S. customers). Sciton Inc.; 2012. Available at: http://www.sciton.com/node/2388 (accessed May 30, 2012).
19. Bessinger GT. Treatment of onychomycosis with the JOULE ClearSense. Sciton Inc.; 2012. Available at: http://scitonclearsense.com/2600-003-10- WhitePaper.pdf (accessed May 30, 2012).
20. Light Age Inc. 510(k) summary K110370. Q-Clear, Light Age. FDA 510(k) premarket notification database; 2011. Available at: http://www.accessdata.fda. gov/cdrh-docs/pdf11/K110370.pdf (accessed May 30, 2012).
21. University of California, Irvine. 1320 nm Nd:YAG laser for improving the appearance of onychomycosis. ClinicalTrials.gov.; 2011. Available at: http://clinicaltrials.gov/ct2/show/NCT01498393 (accessed May 30, 2012).
22. ConBio. Diode laser treatment of onychomycosis. ClinicalTrials.gov; 2011. Available at: http://clinicaltrials.gov/ct2/show/NCT01452490 (accessed May 30, 2012).
23. Brasilia University Hospital. Erbium-doped yttrium aluminium garnet laser (Erb:YAG) associated with amorolfine lacquer in the treatment of onychomycosis (OnychoLASER). ClinicalTrials.gov; 2012. Available at: http://clinicaltrials. gov/ct2/show/NCT01528813 (accessed May 30, 2012).
24. Erchonia Corporation. Study of the use of low level laser light therapy to treat toenail fungus. ClinicalTrials.gov; 2012. Available at: http://clinicaltrials.gov/ct2/show/NCT01534689 (accessed May 30, 2012).
25. Fotona Inc. 510(k) summary K113702. XP Nd:YAG Laser System Family, Fotona Inc. FDA 510(k) premarket notification database; 2012. Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf11/K113702.pdf (accessed May 30, 2012).
26. Aerolase Inc. Skin tightening and hair removal with LightPodNeo. Available at: http://www.aerolase.com/LightPodNeo.html#Specs (accessed: May 30, 2012).
27. Sciton Inc. 510(k) summary K111483. JOULE ClearSense, Sciton Inc. FDA 510(k) premarket notification database; 2011. Available at: http://www. accessdata.fda.gov/cdrh-docs/pdf11/K111483.pdf (accessed May 30, 2012).
28. PinPointe USA. 510(k) summary K093547. PinPointe FootLaser, PinPointe USA Inc. FDA 510(k) premarket notification database; 2010.Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf9/K093547.pdf (accessed May 30, 2012).
29. Cutera Inc. 510(k) summary K103626. GenesisPlus, Cutera Inc. FDA 510(k) premarket notification database; 2011. Available at: http://www.accessdata.fda. gov/cdrh-docs/pdf10/K103626.pdf (accessed May 30, 2012).
30. New Star Lasers Inc. 510(k) summary K103338. CoolTouch VARIA, New Star Lasers Inc. FDA 510(k) premarket notification database; 2011. Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf6/K060966.pdf (accessed May 30, 2012).
31. CoolTouch Inc. CoolTouch. Physicians CoolTouch CT3Plus Laser System. CoolTouch CT3Plus laser specifications. Available at: http://www.cooltouch.com/ CT3Plus-specifications.aspx (accessed May 30, 2012).
32. Alma Lasers. 510(k) summary K113810. Harmony, Alma Lasers Inc. FDA 510(k) premarket notification database; 2012. Available at: http://www.accessdata.fda. gov/cdrh-docs/pdf11/K113810.pdf (accessed May 30, 2012).
33. Bornstein E, Hermans W, Gridley S, Manni J. Near-infrared photoinactivation of bacteria and fungi at physiologic temperatures. Photochem Photobiol 2009;85:1364-74, doi:10.1111/j.1751-1097.2009.00615.x.
34. Vural E, Winfield HL, Shingleton AW, et al. The effects of laser irradiation on Trichophyton rubrum growth. Lasers Med Sci 2008; 23:349-53, doi:10.1007/s10103-007-0492-4.
35. Manevitch Z, Lev D, Hochberg M, et al. Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol 2010;86:476-9, doi:10.1111/j.1751-1097. 2009.00672.x.